ArticleEvidence-based complementary and alternative medicine : eCAM2005
Snake Venom: Any Clue for Antibiotics and CAM?
Article in Evidence-based complementary and alternative medicine : eCAM, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Screening the antimicrobial properties of snake venoms: an iterative fractionation approach.Access microbiology · 2026Article
- Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond.International journal of molecular sciences · 2022Review
- Review
- Article
- Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2.Journal of molecular modeling · 2019Article
- Intradermal Application of Crotamine Induces Inflammatory and Immunological Changes In Vivo.Toxins · 2019Article
- Article
- Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent.FEBS open bio · 2015Article
- Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms.The open microbiology journal · 2015Article
- Cobra cytotoxins: structural organization and antibacterial activity.Acta naturae · 2014Article
- Comparative analysis of viperidae venoms antibacterial profile: a short communication for proteomics.Evidence-based complementary and alternative medicine : eCAM · 2011Article
- Exploring of Antimicrobial Activity of Triphala Mashi-an Ayurvedic Formulation.Evidence-based complementary and alternative medicine : eCAM · 2008Article
- Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins.The Biochemical journal · 2007Article
- eCAM benefits from diversity that derives from CAM.Evidence-based complementary and alternative medicine : eCAM · 2005Article
- Antileukemic potential of PEGylated gold nanoparticle conjugated with protein toxin (NKCT1) isolated from Indian cobra (Cancer nanotechnologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lately several naturally occurring peptides presenting antimicrobial activity have been described in the literature. However, snake venoms, which are an enormous source of peptides, have not been fully explored for searching such molecules. The aim of this work is to review the basis of antimicrobial mechanisms revealing snake venom as a feasible source for searching an antibiotic prototype. Therefore, it includes (i) a description of the constituents of the snake venoms involved in their main biological effects during the envenomation process; (ii) examples of snake venom molecules of commercial use; (iii) mechanisms of action of known antibiotics; and (iv) how the microorganisms can be resistant to antibiotics. This review also shows that snake venoms are not totally unexplored sources for antibiotics and complementary and alternative medicine (CAM).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.